MAR 13, 2015 6:37 AM PDT

Molecule-Making Machine Simplifies Complex Chemistry

WRITTEN BY: Judy O'Rourke
A new molecule-making machine could do for chemistry what 3-D printing did for engineering: Make it fast, flexible, and accessible to anyone.

Chemists at the University of Illinois, led by chemistry professor and medical doctor Martin D. Burke, MD, PhD, built the machine to assemble complex small molecules at the click of a mouse, like a 3-D printer at the molecular level. The automated process has the potential to greatly speed up and enable new drug development and other technologies that rely on small molecules.
A machine in University of Illinois chemistry professor Martin Burke's lab assembles complex small molecules out of simple chemical building blocks, like a 3-D printer on the molecular level.
"We wanted to take a very complex process, chemical synthesis, and make it simple," says Burke, a Howard Hughes Medical Institute Early Career Scientist. "Simplicity enables automation, which, in turn, can broadly enable discovery and bring the substantial power of making molecules to nonspecialists."

The researchers described the technology in a paper featured on the cover of the March 13 issue of Science.

"Small molecules" are a specific class of complex, compact chemical structures found throughout nature. They are very important in medicine - most medications available now are small molecules - as well as in biology as probes to uncover the inner workings of cells and tissues. Small molecules also are key elements in technologies like solar cells and LEDs.

However, small molecules are notoriously difficult to make in a lab. Traditionally, a highly trained chemist spends years trying to figure out how to make each one before its function can even be explored, a slowdown that hinders development of small-molecule-based medications and technologies.

"Up to now, the bottleneck has been synthesis," Burke says. "There are many areas where progress is being slowed, and many molecules that pharmaceutical companies aren't even working on, because the barrier to synthesis is so high."

The main question that Burke's group seeks to answer: How do you take something very complex and make it as simple as possible?

The group's strategy has been to break down the complex molecules into smaller building blocks that can be easily assembled. The chemical building blocks all have the same connector piece and can be stitched together with one simple reaction, the way that a child's interconnecting plastic blocks can have different shapes but all snap together. Many of the building blocks Burke's lab has developed are available commercially.

To automate the building-block assembly, Burke's group devised a simple catch-and-release method that adds one building block at a time, rinsing the excess away before adding the next one. They demonstrated that their machine could build 14 different classes of small molecules, including ones with difficult-to-manufacture ring structures, all using the same automated building-block assembly.

"Dr Burke's research has yielded a significant advance that helps make complex small molecule synthesis more efficient, flexible, and accessible," says Miles Fabian, PhD, National Institutes of Health's National Institute of General Medical Sciences, which partially funded the research. "It is exciting to think about the impact that continued advances in these directions will have on synthetic chemistry and life science research."

The automated synthesis technology has been licensed to REVOLUTION Medicines, Inc, a company Burke co-founded that focuses on creating new medicines based on small molecules found in nature. The company initially is focusing on antifungal medications, an area where Burke's research has already made strides.

"It is expected that the technology will similarly create new opportunities in other therapeutic areas as well, as the industrialization of the technology will help refine and broaden its scope and scalability," Burke says.

"Perhaps most exciting, this work has opened up an actionable roadmap to a general and automated way to make most small molecules," he says. "If that goal can be realized, it will help shift the bottleneck from synthesis to function and bring the power of making small molecules to nonspecialists."

[Source: University of Illinois]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
APR 17, 2020
Chemistry & Physics
APR 17, 2020
Fish Tank Chemicals Aren't COVID-19 Medication, Says FDA
While the medical community is scrambling to find the proper medications for Sars-CoV-02 infection, a significant portio ...
APR 23, 2020
Chemistry & Physics
APR 23, 2020
"Green" Ammonia: Out of Laundry Room, Into Engine Room
The Paris Agreement outlines a series of measures for our society to adopt so that we can reduce greenhouse gas emission ...
APR 26, 2020
Space & Astronomy
APR 26, 2020
Can Planets Be Larger Than Their Host Stars?
When you look at the confines of our solar system and notice just how large the Sun is when compared to Jupiter, the lar ...
MAY 14, 2020
Chemistry & Physics
MAY 14, 2020
Do Organic Chemists Speak an Alien Language?
Have you ever read a detergent label and got confused? Or had trouble understanding a medication recall? Certain ch ...
MAY 03, 2020
Chemistry & Physics
MAY 03, 2020
Using environmental forensics to identify ozone-depleting chemicals
New research published in the journal Geophysical Research Letters highlights some of the shortcomings of the 1987 Montr ...
MAY 06, 2020
Chemistry & Physics
MAY 06, 2020
Electronic nose could detect COPD
An electronic nose capable of identifying respiratory tract infections could come in great handy in times like these. At ...
Loading Comments...